Skip to main content
. 2017 May 23;12(5):e0178204. doi: 10.1371/journal.pone.0178204

Fig 2. Identification of candidate radiosensitizers using a connectivity map.

Fig 2

Genes with a false discovery rate-adjusted p value (p < 0.05) and a fold change >1.5 were considered DEGs. Connectivity mapping between A549 and H460 cells gene signatures is shown. Four drugs show overlap in the top 30 drug list for both lung cancer cell lines.